L

Longevity Biotech

0 followers

Longevity Biotech is developing a new class of therapeutic candidates called Hybridtides. Their focus is on delivering clinically transformative products that tackle the most challenging aspects of medicine today.

Industries

Employees

1-10

Links

Org chart

Scott Shandler's profile picture
Scott Shandler
Founder & CEO
Profile photo

Scott Shandler

Collapse
Samuel Gellman's profile picture
Samuel Gellman
Co-founder And CSO
Uma Sinha's profile picture
Uma Sinha
EVP, Preclinical Development
  1. Something went wrong loading the org chart, please refresh the page.